1-11 of 11
Gerd Ritter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG Protein

Bernardo Sgarbi Reis, Achim A. Jungbluth, Denise Frosina, Megan Holz, Erika Ritter, Eiichi Nakayama, Toshiaki Ishida, Yuichi Obata, Brett Carver, Howard Scher, Peter T. Scardino, Susan Slovin, Sumit K. Subudhi, Victor E. Reuter, Caroline Savage, James P. Allison, Jonathan Melamed, Elke Jäger, Gerd Ritter, Lloyd J. Old, Sacha Gnjatic
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (22): 6112–6125.
https://doi.org/10.1158/1078-0432.CCR-12-3580
Published: 14 November 2013
View article titled, Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG Protein
Open the PDF for Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG Protein in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Paul Sabbatini, Takemasa Tsuji, Luis Ferran, Erika Ritter, Christine Sedrak, Kevin Tuballes, Achim A. Jungbluth, Gerd Ritter, Carol Aghajanian, Katherine Bell-McGuinn, Martee L. Hensley, Jason Konner, William Tew, David R. Spriggs, Eric W. Hoffman, Ralph Venhaus, Linda Pan, Andres M. Salazar, Catherine Magid Diefenbach, Lloyd J. Old, Sacha Gnjatic
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (23): 6497–6508.
https://doi.org/10.1158/1078-0432.CCR-12-2189
Published: 29 November 2012
View article titled, Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
Open the PDF for Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity

Julia Karbach, Antje Neumann, Kathrin Brand, Claudia Wahle, Ekkehard Siegel, Markus Maeurer, Erika Ritter, Takamasa Tsuji, Sacha Gnjatic, Lloyd J. Old, Gerd Ritter, Elke Jäger
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5449–5459.
https://doi.org/10.1158/1078-0432.CCR-12-1116
Published: 30 September 2012
View article titled, Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity
Open the PDF for Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity in another window
Includes: Supplementary data
Journal Articles

Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients

Julia Karbach, Antje Neumann, Akin Atmaca, Claudia Wahle, Kathrin Brand, Lotta von Boehmer, Alexander Knuth, Armin Bender, Gerd Ritter, Lloyd J. Old, Elke Jäger
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (4): 861–870.
https://doi.org/10.1158/1078-0432.CCR-10-1811
Published: 15 February 2011
View article titled, Efficient <em>In vivo</em> Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients
Open the PDF for Efficient <em>In vivo</em> Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients in another window
Includes: Supplementary data
Journal Articles

NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells

Sacha Gnjatic, Nasser K. Altorki, Derek Ng Tang, Shi-Ming Tu, Vikas Kundra, Gerd Ritter, Lloyd J. Old, Christopher J. Logothetis, Padmanee Sharma
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (6): 2130–2139.
https://doi.org/10.1158/1078-0432.CCR-08-2632
Published: 16 March 2009
View article titled, NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells
Open the PDF for NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells in another window
Includes: Supplementary data
Journal Articles

Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

Ali O. Gure, Ramon Chua, Barbara Williamson, Mithat Gonen, Cathy A. Ferrera, Sacha Gnjatic, Gerd Ritter, Andrew J.G. Simpson, Yao-T. Chen, Lloyd J. Old, Nasser K. Altorki
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (22): 8055–8062.
https://doi.org/10.1158/1078-0432.CCR-05-1203
Published: 18 November 2005
View article titled, Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
Open the PDF for Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake

Andrew M. Scott, Fook-Thean Lee, Robert Jones, Wendie Hopkins, Duncan MacGregor, Jonathan S. Cebon, Anthony Hannah, Geoffrey Chong, Paul U, Anthony Papenfuss, Angela Rigopoulos, Susan Sturrock, Roger Murphy, Veronika Wirth, Carmel Murone, Fiona E. Smyth, Simon Knight, Sydney Welt, Gerd Ritter, Elizabeth Richards, Edouard C. Nice, Antony W. Burgess, Lloyd J. Old
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (13): 4810–4817.
https://doi.org/10.1158/1078-0432.CCR-04-2329
Published: 06 July 2005
View article titled, A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake
Open the PDF for A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake in another window
Journal Articles

The Spontaneous CD8+ T-Cell Response to HLA-A2-Restricted NY-ESO-1b Peptide in Hepatocellular Carcinoma Patients

Xiao-Ying Shang, Hong-Song Chen, Hua-Gang Zhang, Xue-Wen Pang, Huan Qiao, Ji-Run Peng, Li-Ling Qin, Ran Fei, Ming-Hui Mei, Xi-Sheng Leng, Sacha Gnjatic, Gerd Ritter, Andrew J. G. Simpson, Lloyd J. Old, Wei-Feng Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6946–6955.
https://doi.org/10.1158/1078-0432.CCR-04-0502
Published: 22 October 2004
View article titled, The Spontaneous CD8<sup>+</sup> T-Cell Response to HLA-A2-Restricted NY-ESO-1b Peptide in Hepatocellular Carcinoma Patients
Open the PDF for The Spontaneous CD8<sup>+</sup> T-Cell Response to HLA-A2-Restricted NY-ESO-1b Peptide in Hepatocellular Carcinoma Patients in another window
Journal Articles

A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer

Andrew M. Scott, Greg Wiseman, Sydney Welt, Alex Adjei, Fook-Thean Lee, Wendie Hopkins, Chaitan R. Divgi, Lorelei H. Hanson, Paul Mitchell, Denise N. Gansen, Steven M. Larson, James N. Ingle, Eric W. Hoffman, Paul Tanswell, Gerd Ritter, Leonard S. Cohen, Peter Bette, Lisa Arvay, Andree Amelsberg, Dan Vlock, Wolfgang J. Rettig, Lloyd J. Old
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (5): 1639–1647.
Published: 01 May 2003
View article titled, A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer
Open the PDF for A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer in another window
Journal Articles

Preliminary Report of a Phase I Study of Combination Chemotherapy and Humanized A33 Antibody Immunotherapy in Patients with Advanced Colorectal Cancer

Sydney Welt, Gerd Ritter, Clarence Williams, Jr., Leonard S. Cohen, Achim Jungbluth, Elizabeth A. Richards, Lloyd J. Old, Nancy E. Kemeny
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (4): 1347–1353.
Published: 01 April 2003
View article titled, Preliminary Report of a Phase I Study of Combination Chemotherapy and Humanized A33 Antibody Immunotherapy in Patients with Advanced Colorectal Cancer
Open the PDF for Preliminary Report of a Phase I Study of Combination Chemotherapy and Humanized A33 Antibody Immunotherapy in Patients with Advanced Colorectal Cancer in another window
Journal Articles

Phase I Study of Anticolon Cancer Humanized Antibody A33

Sydney Welt, Gerd Ritter, Clarence Williams, Jr., Leonard S. Cohen, Mary John, Achim Jungbluth, Elizabeth A. Richards, Lloyd J. Old, Nancy E. Kemeny
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (4): 1338–1346.
Published: 01 April 2003
View article titled, Phase I Study of Anticolon Cancer Humanized Antibody A33
Open the PDF for Phase I Study of Anticolon Cancer Humanized Antibody A33 in another window